Polycystic ovary syndrome and the peripheral blood white cell count

References

• AngeliF, AngeliE, AmbrosioG, MazzottaG, ReboldiG, VerdecchiaP. 2010. Neutrophil count for the identification of postmenopausal hypertensive women at increased cardiovascular risk. Obstetrics and Gynecology115:695–703.
   PubMed Web of Science ®Google Scholar
• AzzizzR, WoodsKS, ReynaR, KeyTJ, KnochenhauerES, YildizBO. 2004. The prevalence and features of the polycystic ovary syndrome in an unselected population. Journal of Clinical Endocrinology and Metabolism89:2745–2749.
   PubMedGoogle Scholar
• BalenA, RajkowhaM. 2003. Polycystic ovary syndrome – a systematic disorder?Best Practice and Research Clinical Obstetrics and Gynaecology17:263–274.
   PubMedGoogle Scholar
• BerlinerS, RogowskiO, RotsteinR, FusmanR, Shapira I BornsteinNM. 2000. Activated polymorphonuclear leucocytes and monocytes in the peripheral blood of patients with ischemic heart and brain conditions corresponded to the presence of multiple risk factors for atherothrombosis. Cardiology94:19–25.
   PubMed Web of Science ®Google Scholar
• Brunner HuberLR. 2007. Validity of self-reported height and weight in women of reproductive age. Maternal and Child Health Journal11:137–144.
   PubMed Web of Science ®Google Scholar
• Diamanti-KandarakisE, PaterakisT, AlexandrakiK, PiperiC, AessoposA, KatsikisI. 2006. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin. Human Reproduction21:1426–1431.
   PubMed Web of Science ®Google Scholar
• FattahC, FarahN, O'TooleF, BarryS, StuartB, TurnerMJ. 2009a. Body mass index (BMI) in women booking for antenatal care: comparison between self-reported and digital measurements. European Journal of Obstetrics, Gynecology and Reproductive Biology144:32–34.
   PubMed Web of Science ®Google Scholar
• FattahC, FarahN, O'ConnorN, StuartB, TurnerMJ. 2009b. The measurement of maternal adiposity. Journal of Obstetrics and Gynaecology29:686–689.
   Web of Science ®Google Scholar
• FattahCFarahN, BarryS, O'ConnorN, StuartB, TurnerMJ. 2010. Maternal weight and body composition in the first trimester of pregnancy. Acta Obstetricia et Gynecologica Scandinavica89:952–955.
   PubMed Web of Science ®Google Scholar
• FranksS. 2006. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. Journal of Clinical Endocrinology and Metabolism91:786–789.
   PubMed Web of Science ®Google Scholar
• GlintborgD, AndersenM. 2010. An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome. Gynecological Endocrinology26:281–296.
   PubMed Web of Science ®Google Scholar
• HarborneL, FlemingR, LyallH, NormanJ, SattarN. 2003. Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet361:1894–1901.
   PubMed Web of Science ®Google Scholar
• HevenerAL, FebbraioMA; Stock Conference Working Group. 2010. The 2009 stock conference report: inflammation, obesity and metabolic disease. Obesity Reviews11:635–644.
   PubMed Web of Science ®Google Scholar
• IbanezL, JaramilloAM, FerrerA, de ZegherF. 2005. High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception. Human Reproduction20:2457–2462.
   PubMed Web of Science ®Google Scholar
• Juge-AubryCE, HenrichotE, MeierCA. 2005. Adipose tissue: a regulator of inflammation. Best Practice and Research Clinical Endocrinology and Metabolism19:547–566.
   PubMed Web of Science ®Google Scholar
• KellyCJ, LyallH, PetrieJR, GouldGW, ConnellJM, SattarN. 2001. Low grade chronic inflammation in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism86:2453–2455.
   PubMed Web of Science ®Google Scholar
• Naruko , Ueda M, Haze K, van der Wal AC, van der Loos CM, Itoh A. 2002. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation106:2894–2900.
   PubMed Web of Science ®Google Scholar
• OrioF, PalombaS, CascellaT, Di BiaseS, MangusoF, TauchmanovaL. 2005. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism90:2–5.
   PubMed Web of Science ®Google Scholar
• PalombaS, FalboA, ZulloF, OrioF. 2009. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocrinology Reviews30:1–50.
   PubMed Web of Science ®Google Scholar
• PuderJJ, VargaS, KraenzlinM, de GeyterC, KellerU, MullerB. 2005. Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance. Journal of Clinical Endocrinology and Metabolism90:6014–6021.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction19:41–47.
   PubMed Web of Science ®Google Scholar
• SathyapalanT, AtkinS. 2010. Mediators of inflammation in polycystic ovary syndrome in relation to adiposity. Mediators of Inflammation2010:758656.
   PubMed Web of Science ®Google Scholar
• ThomannR, RossinelliN, KellerU, TirriBF, de GeyterC, RuizJ. 2008. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome. Gynecology and Endocrinology24:199–206.
   PubMed Web of Science ®Google Scholar
• VillanuevaEV. 2001. The validity of self-reported weight in US adults: a population based cross-sectional study. BMC Public Health1:11.
   PubMed Web of Science ®Google Scholar